Akanocure Pharmaceuticals, Inc.

United States of America

Back to Profile
1-4 of 4 for Akanocure Pharmaceuticals, Inc. Sort by
Query
Aggregations
Jurisdiction
        United States 2
        Canada 1
        World 1
Date
2023 1
2021 1
Before 2020 1
IPC Class
C07F 7/04 - Esters of silicic acids 4
C07F 7/18 - Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages 4
C07D 309/30 - Oxygen atoms, e.g. delta-lactones 3
Status
Pending 2
Registered / In Force 2
Found results for  patents

1.

SCALABLE POLYPROPIONATE LACTONE STEREOTETRADS

      
Application Number 17947784
Status Pending
Filing Date 2022-09-19
First Publication Date 2023-06-15
Owner AKANOCURE PHARMACEUTICALS, INC. (USA)
Inventor
  • Noshi, Mohammad N.
  • Fuchs, Philip L.

Abstract

The present technology is directed to polypropionate lactone stereotetrads of Formula (I) (or a pharmaceutically acceptable salt and/or solvate thereof) which are significant intermediates for multiple synthetic applications. The present technology is directed to polypropionate lactone stereotetrads of Formula (I) (or a pharmaceutically acceptable salt and/or solvate thereof) which are significant intermediates for multiple synthetic applications.

IPC Classes  ?

  • C07F 7/18 - Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
  • C07F 7/04 - Esters of silicic acids

2.

Scalable polypropionate lactone stereotetrads

      
Application Number 17070115
Grant Number 11447509
Status In Force
Filing Date 2020-10-14
First Publication Date 2021-09-09
Grant Date 2022-09-20
Owner AKANOCURE PHARMACEUTICALS, INC. (USA)
Inventor
  • Noshi, Mohammad N.
  • Fuchs, Philip L.

Abstract

The present technology is directed to polypropionate lactone stereotetrads of Formula (I) (or a pharmaceutically acceptable salt and/or solvate thereof) which are significant intermediates for multiple synthetic applications.

IPC Classes  ?

  • C07F 7/04 - Esters of silicic acids
  • C07D 309/30 - Oxygen atoms, e.g. delta-lactones
  • C07F 7/18 - Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages

3.

SCALABLE POLYPROPIONATE LACTONE STEREOTETRADS

      
Application Number US2017065652
Publication Number 2018/107180
Status In Force
Filing Date 2017-12-11
Publication Date 2018-06-14
Owner AKANOCURE PHARMACEUTICALS, INC. (USA)
Inventor
  • Noshi, Mohammad N.
  • Fuchs, Philip L.

Abstract

The present technology is directed to polypropionate lactone stereotetrads of Formula (I) (or a pharmaceutically acceptable salt and/or solvate thereof) which are significant intermediates for multiple synthetic applications.

IPC Classes  ?

  • C07D 309/30 - Oxygen atoms, e.g. delta-lactones
  • C07F 7/04 - Esters of silicic acids
  • C07F 7/18 - Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages

4.

SCALABLE POLYPROPIONATE LACTONE STEREOTETRADS

      
Document Number 03046358
Status Pending
Filing Date 2017-12-11
Owner
  • AKANOCURE PHARMACEUTICALS, INC. (USA)
  • NOSHI, MOHAMMAD N. (USA)
  • FUCHS, PHILIP L. (USA)
Inventor
  • Noshi, Mohammad N.
  • Fuchs, Philip L.

Abstract

The present technology is directed to polypropionate lactone stereotetrads of Formula (I) (or a pharmaceutically acceptable salt and/or solvate thereof) which are significant intermediates for multiple synthetic applications.

IPC Classes  ?

  • C07D 309/30 - Oxygen atoms, e.g. delta-lactones
  • C07F 7/04 - Esters of silicic acids
  • C07F 7/18 - Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages